GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
7.19
+0.11 (1.55%)
At close: Apr 26, 2024, 4:00 PM
7.20
+0.01 (0.14%)
After-hours: Apr 26, 2024, 7:28 PM EDT

Company Description

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.

It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.

The company was founded in 2011 and is headquartered in Santa Monica, California.

GoodRx Holdings, Inc.
GoodRx Holdings logo
Country United States
IPO Date Sep 23, 2020
Industry Health Information Services
Sector Healthcare
Employees 694
CEO Scott W. Wagner

Contact Details

Address:
2701 Olympic Boulevard
Santa Monica, California 90404
United States
Phone (855) 268-2822
Website goodrx.com

Stock Details

Ticker Symbol GDRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $33.00
CIK Code 0001809519
CUSIP Number 38246G108
ISIN Number US38246G1085
Employer ID 47-5104396
SIC Code 7374

Key Executives

Name Position
Trevor Bezdek Co-founder and Chairman
Douglas Joseph Hirsch Co-founder, Chief Mission Officer and Director
Karsten Ian Voermann Chief Financial Officer and Principal Financial Officer
Romin Nabiey Chief Accounting Officer and Principal Accounting Officer
Scott W. Wagner Interim Chief Executive Officer and Principal Operating Officer
Mike Walsh President and Executive Vice President of Prescription Marketplace
Whitney Notaro Vice President of Investor Relations
Gracye Cheng General Counsel and Secretary
Andrew Slutsky Chief Marketing Officer
Vina M. Leite Chief People Officer

Latest SEC Filings

Date Type Title
Apr 25, 2024 ARS Filing
Apr 25, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2024 DEF 14A Other definitive proxy statements
Apr 5, 2024 S-3 Registration statement under Securities Act of 1933
Mar 14, 2024 8-K Current Report
Mar 8, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Mar 8, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Mar 7, 2024 8-K Current Report
Mar 7, 2024 8-K Current Report
Feb 29, 2024 S-8 Securities to be offered to employees in employee benefit plans